Search results for: Roche
Filter search results
Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA
11 April 2023
…in HTA: what is the future? Roche Reference: M-GB-00010454 Date of Preparation: March 2023 Roche makes no warranties or representations of any kind as to the accuracy, completeness, reliability or…
Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology
1 June 2018
…support the assumption that the QoL of LTCS can be similar to that of age/sex-matched population samples. This study was funded by Roche Products Ltd. Cancer survival rates have improved…
Learnings from the Assessments of Entrectinib and Larotrectinib: Health Technology Assessment Challenges Associated with Tumour-Agnostic Therapies
1 January 2022
…to ensure that future tumour-agnostic therapies are assessed consistently. Funding: This consulting report was commissioned and funded by F. Hoffmann-La Roche Ltd. Medical writing support for the development of this…
OHE Lunchtime Seminar: ‘Age, Utilities, and Self-Reported Health: Issues for HTA’
17 May 2016, 11:00pm
…This piece of research is based on findings from a research study performed by OHE and Roche Products Ltd and funded by Roche Products Ltd. Views expressed in the seminar…
The Value of Diagnostic information (VODI) in Heart Failure – Recognising Value Beyond ‘Beats-Per-Minute’
3 December 2020
Bernarda Zamora presented at the virtual event entitled ‘Value of Diagnostic Information in Heart Failure’, which was organised by Roche Diagnostics. The panel, composed of six experts representing a range…
Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Cancer Treatments
8 January 2021
…from F.Hoffmann-la Roche Ltd. for running this session. Rodes Sanchez M., Henderson N., Steuten L., 2020. Bridging the Gap: Pathways for Regulatory and Health Technology Assessment of Histology Independent Medicines….
Save the Date: Drug Development in 2022, OHE’s 50th Anniversary Conference
21 June 2012
…Professor Patricia Danzon, The Wharton School, University of Pennsylvania Dr Hans-Georg Eichler, Senior Medical Officer, European Medicines Agency Dr Jens Grueger, Head, Global Health Economics and Pricing, Roche Pharmaceuticals Dr…
The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region
14 April 2025
…This consulting report ‘The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region’ was commissioned and funded by Roche, MSD, and Johnson & Johnson….
Paul Catchpole
11 December 2023
…of management posts before working on a wide range of UK and international management consultancy assignments at PriceWaterhouseCoopers. After moving to Roche, he led work on national reimbursement of medicines,…